Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep 6:4:146.
doi: 10.3389/fmed.2017.00146. eCollection 2017.

Mean Platelet Volume and Immature Platelet Fraction in Autoimmune Disorders

Deonilson Schmoeller  1 , Maria Mercedes Picarelli  1 , Terezinha Paz Munhoz  2 , Carlos Eduardo Poli de Figueiredo  3 , Henrique Luiz Staub  1
Affiliations
Review

Mean Platelet Volume and Immature Platelet Fraction in Autoimmune Disorders

Deonilson Schmoeller et al. Front Med (Lausanne). .

Abstract

Mean platelet volume (MPV), measured using automated blood analysers, has been appraised as a potential biomarker in cardiovascular disease, diabetes mellitus, and cancer. The test, a useful tool in differentiation of thrombocytopenic states, has now been carried out for autoimmune disorders, but data are yet scarce. Controversial results have been obtained in systemic and organ-specific autoimmune disorders. Another test, the immature platelet fraction (IPF) reflects the amount of young, reticulated platelets. IPF is calculated by automated hematology analysis or flow cytometry, and it is usually high in patients with rapid platelet destruction. For both MPV and IPF, standardization of cutoff is a major need. In this review, we focus the current applicability of MPV and IPF as biomarkers in patients with autoimmune diseases.

Keywords: autoimmune diseases; immature platelet fraction; mean platelet volume; platelet size; platelet volume.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood (2015) 126(5):582–8.10.1182/blood-2014-08-531582 - DOI - PMC - PubMed
    1. McNicol A, Israels SJ. Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets (2008) 8(2):99–117.10.2174/187152908784533739 - DOI - PubMed
    1. Boilard E, Blanco P, Nigrovic PA. Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol (2012) 8(9):534–42.10.1038/nrrheum.2012.118 - DOI - PubMed
    1. Paulus JM. Platelet size in man. Blood (1975) 46(3):321–36. - PubMed
    1. Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med (2012) 44(8):805–16.10.3109/07853890.2011.653391 - DOI - PubMed

LinkOut - more resources